Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Apparent SMA I unlinked to 5q

J M Cobben¹, H Scheffer, M de Visser

¹Department of Medical Genetics, Antonius Deusinglaan, Groningen, The Netherlands.

Journal of Medical Genetics

|March 1, 1994

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Receptor for advanced glycation end products (RAGE) polymorphisms are associated with systemic lupus erythematosus and disease severity in lupus nephritis.

Lupus·2012

Same author

Huntingtin with an expanded polyglutamine repeat affects the Jab1-p27(Kip1) pathway.

Neurobiology of disease·2012

Same author

An extensive screen of the HLA region reveals an independent association of HLA class I and class II with susceptibility for systemic lupus erythematosus.

Scandinavian journal of rheumatology·2009

Same author

Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort.

Gut·2008

Same author

Towards harmonisation of outcome measures for DMD and SMA within TREAT-NMD; report of three expert workshops: TREAT-NMD/ENMC workshop on outcome measures, 12th--13th May 2007, Naarden, The Netherlands; TREAT-NMD workshop on outcome measures in experimental trials for DMD, 30th June--1st July 2007, Naarden, The Netherlands; conjoint Institute of Myology TREAT-NMD meeting on physical activity monitoring in neuromuscular disorders, 11th July 2007, Paris, France.

Neuromuscular disorders : NMD·2008

Same author

Analysis of C1q polymorphisms suggests association with systemic lupus erythematosus, serum C1q and CH50 levels and disease severity.

Annals of the rheumatic diseases·2008

This study describes a case of Spinal Muscular Atrophy (SMA) type I not linked to chromosome 5q. Consanguinity in the parents suggests a potential second SMA locus, impacting genetic counseling and prenatal diagnosis strategies.

Area of Science:

Genetics
Neurology
Pediatrics

Background:

Spinal Muscular Atrophy (SMA) type I is a severe genetic neuromuscular disorder.
The primary genetic cause of SMA is mutations in the SMN1 gene on chromosome 5q.
Prenatal diagnosis typically relies on DNA analysis linked to the 5q locus.

Observation:

A proband presented with clinical symptoms identical to SMA type I.
The proband's parents were second cousins (consanguineous).
DNA analysis revealed the proband and a healthy sibling shared identical haplotypes for markers near the 5q SMA locus.

Findings:

The genetic markers indicated non-linkage of the SMA phenotype to chromosome 5q in this family.
The consanguinity of the parents raised suspicion for an autosomal recessive SMA type I locus distinct from the known 5q region.

Related Experiment Videos

This case challenges the assumption that all SMA type I cases are linked to chromosome 5q.

Implications:

The findings suggest the possibility of a second genetic locus for autosomal recessive SMA type I.
This has significant implications for genetic counseling, particularly in consanguineous families undergoing prenatal diagnosis.
It underscores the importance of including all healthy siblings in prenatal DNA studies for SMA type I to ensure accurate genetic assessment.